PBMCs obtained from 11 patients with CLL were treated with relatlimab and T cell production of TNF-α, IFN-γ and IL-2 was measured by intracellular staining and flow cytometry analysis (Figure 6). This evidence concerns the gene IFNG and B-cell chronic lymphocytic leukemia.